alendronate has been researched along with Camurati-Engelmann Disease in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Camurati-Engelmann disease (CED) is a genetic bone-modeling disorder mainly caused by mutations in the gene that encodes transforming growth factor-β1 (TGF-β1)." | 1.48 | Bone-targeted delivery of TGF-β type 1 receptor inhibitor rescues uncoupled bone remodeling in Camurati-Engelmann disease. ( Cao, X; Ding, Q; Ding, S; Qin, Y; Tang, S; Zhen, G, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qin, Y | 1 |
| Tang, S | 1 |
| Zhen, G | 1 |
| Ding, Q | 1 |
| Ding, S | 1 |
| Cao, X | 1 |
| Iba, K | 1 |
| Takada, J | 1 |
| Kamasaki, H | 1 |
| Oda, T | 1 |
| Hatakeyama, N | 1 |
| Wada, T | 1 |
| Yamashita, T | 1 |
2 other studies available for alendronate and Camurati-Engelmann Disease
| Article | Year |
|---|---|
Bone-targeted delivery of TGF-β type 1 receptor inhibitor rescues uncoupled bone remodeling in Camurati-Engelmann disease.
Topics: Alendronate; Animals; Bone Remodeling; Camurati-Engelmann Syndrome; Cells, Cultured; Disease Models, | 2018 |
A significant improvement in lower limb pain after treatment with alendronate in two cases of Camurati-Engelmann disease.
Topics: Adolescent; Adult; Alendronate; Camurati-Engelmann Syndrome; Child; Female; Femur; Humans; Male; Pai | 2008 |